Postoperative Recovery and Comfort in Patients Undergoing Urologic Robotic Surgery

Sponsor
Linkoeping University (Other)
Overall Status
Completed
CT.gov ID
NCT04694950
Collaborator
(none)
30
1
11
2.7

Study Details

Study Description

Brief Summary

Previously published studies show that adding intrathecal morphine to general anesthesia can reduce the postoperative pain and length of stay (LOS) in varies types of surgery. A recent meta-analysis showed that the addition of intrathecal morphine at doses below 500µg did not increase the risk of respiratory depression compared with a control group receiving intravenous opioids. Epidural analgesia is uncommonly used for robot-assisted laparoscopic procedures due to the limited surgical trauma. In addition, the risks associated with the epidural itself such as infection and spinal hematoma are thought to outweigh its possible benefits for these procedures.

At Linkoping University Hospital a combination of general anesthesia and intrathecal morphine in robot-assisted laparoscopic radical prostatectomy and in robotic-assisted laparoscopic cystectomy is now routinely used in order to improve postoperative recovery. However whether this approach is beneficial in other types of robotic-assisted urological procedures is unknown.

Therefore the investigators aim to conduct a feasibility study for the use of intrathecal morphine combined with general anaesthesia in adult patients undergoing elective urologic laparoscopic robot-assisted surgery at Linkoping University Hospital. The investigators will include 30 patients in the study. The specific aims are to investigate the feasibility and sensitivity of Quality of Recovery 15 (QoR15), as an outcome tool measuring postoperative well-being in this patient cohort.

The investigators will also investigate the feasibility of other outcome measures such as postoperative pain, post-anesthesia care unit LOS, occurrence of pruritus and hospital LOS.

For planning of the timeframe of the future interventional study the investigators will use this feasibility study to examine the inclusion rate of study patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Usual care

Study Design

Study Type:
Observational
Actual Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Postoperative Recovery and Comfort After Urologic Robotic Surgery: A Feasibility Study
Actual Study Start Date :
Dec 30, 2020
Actual Primary Completion Date :
Oct 19, 2021
Actual Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Group feasibility

Adults undergoing elective urologic laparoscopic robotic surgery.

Procedure: Usual care
Intravenous morphine according to clinician´s discretion.

Outcome Measures

Primary Outcome Measures

  1. Change in Quality of Recovery 15 (QoR-15) score [Preoperative, postoperative up to day 7]

    Quality of Recovery 15. A total of 15 questions each answered with a value from 0 to 10. The minimum value of the QoR-15 is 0 and the maximum value is 150. A higher value means a better outcome.

Secondary Outcome Measures

  1. Postoperative pain [Up to postoperative day 3]

    Measurement of pain in rest and in movement with the Numeric Rating Scale (NRS) Pain Scale. Minimum value is 0 (no pain) and maximum value is 10 (extreme pain).

  2. PONV [Up to postoperative day 3]

    Measurement of the frequency of postoperative nausea and vomiting (PONV).

  3. Return of bowel function [Up to postoperative day 7]

    Time to first passing of flatus and first passing of stool.

  4. Postoperative complications [Up to postoperative day 30]

    Using the Clavien-Dindo Classification

  5. Length of hospital stay [Up to 30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Scheduled for elective urologic robotic assisted laparoscopic surgery in Linkoping University Hospital
Exclusion Criteria:
  • Age <18

  • Not expected to comprehend the written or verbal study information

  • Patient planned for robotic assisted laparoscoic prostatectomy or robotic assisted laparoscopic cystectomy

  • Acute surgery

  • ASA class >3

  • Major surgery on another organ planned at the same operation

  • Patient planned for a neuraxial blockade in addition to general anaesthesia.

  • Study personal not available

Contacts and Locations

Locations

Site City State Country Postal Code
1 Linkoping University Hospital Linköping Sweden

Sponsors and Collaborators

  • Linkoeping University

Investigators

  • Study Director: Michelle Chew, MD PhD, Linkoping University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martin Holmberg, Principal investigator, Linkoeping University
ClinicalTrials.gov Identifier:
NCT04694950
Other Study ID Numbers:
  • 210101
First Posted:
Jan 5, 2021
Last Update Posted:
Apr 6, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 6, 2022